Literature DB >> 15357831

Melatonin, melatonin receptors and melanophores: a moving story.

David Sugden1, Kathryn Davidson, Kate A Hough, Muy-Teck Teh.   

Abstract

Melatonin (5-methoxy N-acetyltryptamine) is a hormone synthesized and released from the pineal gland at night, which acts on specific high affinity G-protein coupled receptors to regulate various aspects of physiology and behaviour, including circadian and seasonal responses, and some retinal, cardiovascular and immunological functions. In amphibians, such as Xenopus laevis, another role of melatonin is in the control of skin coloration through an action on melanin-containing pigment granules (melanosomes) in melanophores. In these cells, very low concentrations of melatonin activate the Mel(1c) receptor subtype triggering movement of granules toward the cell centre thus lightening skin colour. Mel(1c) receptor activation reduces intracellular cAMP via a pertussis toxin-sensitive inhibitory G-protein (Gi), but how this and other intracellular signals regulate pigment movement is not yet fully understood. However, melanophores have proven an excellent model for the study of the molecular mechanisms which coordinate intracellular transport. Melanosome transport is reversible and involves both actin- (myosin V) and microtubule-dependent (kinesin II and dynein) motors. Melanosomes retain both kinesin and dynein during anterograde and retrograde transport, but the myosin V motor seems to be recruited to melanosomes during dispersion, where it assists kinesin II in dominating dynein thus driving net dispersion. Recent work suggests an important role for dynactin in coordinating the activity of the opposing microtubule motors. The melanophore pigment aggregation response has also played a vital role in the ongoing effort to devise specific melatonin receptor antagonists. Much of what has been learnt about the parts of the melatonin molecule required for receptor binding and activation has come from detailed structure-activity data using novel melatonin ligands. Work aiming to devise ligands specific for the distinct melatonin receptor subtypes stands poised to deliver selective agonists and antagonists which will be valuable tools in understanding the role of this enigmatic hormone in health and disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15357831     DOI: 10.1111/j.1600-0749.2004.00185.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  18 in total

Review 1.  Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology.

Authors:  Neeraj Joshi; Joyshree Biswas; C Nath; Sarika Singh
Journal:  Mol Neurobiol       Date:  2014-08-27       Impact factor: 5.590

2.  Mitochondrial transfer between cells can rescue aerobic respiration.

Authors:  Jeffrey L Spees; Scott D Olson; Mandolin J Whitney; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

3.  International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.

Authors:  Margarita L Dubocovich; Philippe Delagrange; Diana N Krause; David Sugden; Daniel P Cardinali; James Olcese
Journal:  Pharmacol Rev       Date:  2010-07-06       Impact factor: 25.468

4.  von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis.

Authors:  Rajkumar Noubade; Roxana del Rio; Benjamin McElvany; James F Zachary; Jason M Millward; Denisa D Wagner; Halina Offner; Elizabeth P Blankenhorn; Cory Teuscher
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307

5.  The dynamic properties of intermediate filaments during organelle transport.

Authors:  Lynne Chang; Kari Barlan; Ying-Hao Chou; Boris Grin; Margot Lakonishok; Anna S Serpinskaya; Dale K Shumaker; Harald Herrmann; Vladimir I Gelfand; Robert D Goldman
Journal:  J Cell Sci       Date:  2009-07-28       Impact factor: 5.285

Review 6.  Melatonin: does it have utility in the treatment of haematological neoplasms?

Authors:  Tian Li; Zhi Yang; Shuai Jiang; Wencheng Di; Zhiqiang Ma; Wei Hu; Fulin Chen; Russel J Reiter; Yang Yang
Journal:  Br J Pharmacol       Date:  2017-09-09       Impact factor: 8.739

7.  Expression of MT2 receptor in patients with gastric adenocarcinoma and its relationship with clinicopathological features.

Authors:  Nafiseh Nasri Nasrabadi; Ramin Ataee; Saeid Abediankenari; Mohammad Shokrzadeh; Mojtaba Najafi; Seyed Vahid Hoseini; Hamed Haghi Amin Jan
Journal:  J Gastrointest Cancer       Date:  2014-03

Review 8.  Possible application of melatonin treatment in human diseases of the biliary tract.

Authors:  Leonardo Baiocchi; Tianhao Zhou; Suthat Liangpunsakul; Lenci Ilaria; Martina Milana; Fanyin Meng; Lindsey Kennedy; Praveen Kusumanchi; Zhihong Yang; Ludovica Ceci; Shannon Glaser; Heather Francis; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-11       Impact factor: 4.052

9.  NMDA-R inhibition affects cellular process formation in Tilapia melanocytes; a model for pigmented adrenergic neurons in process formation and retraction.

Authors:  Olalekan Michael Ogundele; Adetokunbo Adedotun Okunnuga; Temitope Deborah Fabiyi; Olayemi Joseph Olajide; Ibukun Dorcas Akinrinade; Philip Adeyemi Adeniyi; Abiodun Ayodele Ojo
Journal:  Metab Brain Dis       Date:  2013-11-17       Impact factor: 3.584

10.  Sleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the rat.

Authors:  Simon P Fisher; David Sugden
Journal:  Neurosci Lett       Date:  2009-04-07       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.